1. 1157. Clinical Safety, Efficacy, and Pharmacokinetics of Fosmanogepix, a Novel First-in-class Antifungal, in Patients with Renal Insufficiency: Subset Analysis from a Phase 2 Candidemia Trial. (31st December 2020) Authors: Bulpa, Pierre; Rahav, Galia; Oren, Ilana; Aoun, Mickaël; Thompson, George R; Pappas, Peter; Kullberg, Bart Jan; Vazquez, Jose A; Barbat, Sara; Wedel, Pamela; Schlamm, Haran T; Hodges, Michael Journal: Open forum infectious diseases Issue: Volume 7:Number 1(2020) Supplement Page Start: S605 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 147. Clinical Safety and Efficacy of Novel Antifungal, Fosmanogepix, in the Treatment of Candidemia: Results from a Phase 2 Proof of Concept Trial. (31st December 2020) Authors: Pappas, Peter; Kullberg, Bart Jan; Vazquez, Jose A; Oren, Ilana; Rahav, Galia; Aoun, Mickaël; Bulpa, Pierre; Ben-Ami, Ronen; Ferrer, Ricard; McCarty, Todd P; Thompson III, George R; Barbat, Sara; Wedel, Pamela; Oborska, Iwonka; Schlamm, Haran T; Hodges, Michael Journal: Open forum infectious diseases Issue: Volume 7:Number 1(2020) Supplement Page Start: S203 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 1490. Serious Infections Caused by Carbapenem Susceptible and Carbapenem Resistant Acinetobacter baumannii-calcoaceticus Complex - A Retrospective Review. (31st December 2020) Authors: Rana, Khurram; Wunderink, Richard G; Tsuei, Betty J; Rahav, Galia; Kovalchuk, Eugenii; Koksal, Iftihar; Maloney, Kathleen; Srinivasan, Subasree Journal: Open forum infectious diseases Issue: Volume 7:Number 1(2020) Supplement Page Start: S747 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 635. Efficacy, Pharmacokinetics (PK), and Safety Profile of MEDI3902, an Anti-Pseudomonas aeruginosa Bispecific Human Monoclonal Antibody in Mechanically Ventilated Intensive Care Unit Patients; Results of the Phase 2 EVADE Study Conducted by the Public-Private COMBACTE-MAGNET Consortium in the Innovative Medicines Initiative (IMI) Program. (31st December 2020) Authors: Chastre, Jean; François, Bruno; Bourgeois, Marc; Komnos, Apostolos; Ferrer, Ricard; Rahav, Galia; De Schryver, Nicolas; Lepape, Alain; Koksal, Iftihar; Luyt, Charles-Edouard; Garcia, Miguel Sanchez; Torres, Antoni; Holland, Thomas L; Holland, Thomas L; Ali, Omar; Shoemaker, Kathryn; Ren, Pin; Ruz... Journal: Open forum infectious diseases Issue: Volume 7:Number 1(2020) Supplement Page Start: S377 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. 824An Open-Label Phase 3 Study of Isavuconazole (VITAL): Focus on Mucormycosis. (December 2014) Authors: Marty, Francisco M.; Perfect, John R.; Cornely, Oliver A.; Mullane, Kathleen M.; Rahav, Galia; Lee, Misun; Ito, Masanori; Maher, Rochelle; Zeiher, Bernhardt; Ostrosky-Zeichner, Luis Journal: Open forum infectious diseases Issue: Volume 1(2014)Supplement 1 Page Start: S235 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. A Phase 2, Randomized, Double-blind, Placebo-Controlled Trial of Presatovir for the Treatment of Respiratory Syncytial Virus Upper Respiratory Tract Infection in Hematopoietic-Cell Transplant Recipients. (3rd December 2019) Authors: Chemaly, Roy F; Dadwal, Sanjeet S; Bergeron, Anne; Ljungman, Per; Kim, Yae-Jean; Cheng, Guang-Shing; Pipavath, Sudhakar N; Limaye, Ajit P; Blanchard, Elodie; Winston, Drew J; Stiff, Patrick J; Zuckerman, Tsila; Lachance, Silvy; Rahav, Galia; Small, Catherine B; Mullane, Kathleen M; Patron, Robert... Journal: Clinical infectious diseases Issue: Volume 71:Number 11(2020) Page Start: 2777 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. A unique megaplasmid contributes to stress tolerance and pathogenicity of an emergent Salmonella enterica serovar Infantis strain. (7th January 2014) Authors: Aviv, Gili; Tsyba, Katherine; Steck, Natalie; Salmon‐Divon, Mali; Cornelius, Antje; Rahav, Galia; Grassl, Guntram A,; Gal‐Mor, Ohad Journal: Environmental microbiology Issue: Volume 16:Number 4(2014:Apr.) Page Start: 977 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Bezlotoxumab for Prevention of Recurrent Clostridium difficile Infection in Patients at Increased Risk for Recurrence. (10th March 2018) Authors: Gerding, Dale N; Kelly, Ciaran P; Rahav, Galia; Lee, Christine; Dubberke, Erik R; Kumar, Princy N; Yacyshyn, Bruce; Kao, Dina; Eves, Karen; Ellison, Misoo C; Hanson, Mary E; Guris, Dalya; Dorr, Mary Beth Journal: Clinical infectious diseases Issue: Volume 67:Number 5(2018) Page Start: 649 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. BNT162b2 mRNA COVID-19 vaccination in immunocompromised patients: A prospective cohort study. (November 2021) Authors: Rahav, Galia; Lustig, Yaniv; Lavee, Jacob; Ohad Benjamini, ; Magen, Hila; Hod, Tammy; Noga Shem-Tov, ; Shmueli, Einat Shacham; Drorit Merkel, ; Ben-Ari, Ziv; Halperin, Rebecca; Indenbaum, Victoria; Olmer, Liraz; Huppert, Amit; Mor, Eytan; Regev-Yochay, Gili; Cohen, Carmit; Finesod, Anat Wieder-; ... Journal: EClinicalMedicine Issue: Volume 41(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. BNT162b2 Vaccination Before Heart Transplantation: Kinetics of the Antibody Response. Issue 3 (29th October 2021) Authors: Peled, Yael; Ram, Eilon; Sternik, Leonid; Segev, Amit; Wieder-Finesod, Anat; Mandelboim, Michal; Indenbaum, Victoria; Beigel, Roy; Levy, Itzchak; Raanani, Ehud; Lustig, Yaniv; Rahav, Galia Journal: Transplantation Issue: Volume 106:Issue 3(2022) Page Start: e190 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗